Zobrazeno 1 - 10
of 22
pro vyhledávání: '"torasemid"'
Publikováno v:
Системные гипертензии, Vol 14, Iss 3, Pp 72-78 (2017)
The article considers issues of efficiency and safety of the use of torasemid, a loop diuretic, with the additional property of antagonist of the mineralocorticoid receptor in the treatment of arterial hypertension in different groups of patients.
Externí odkaz:
https://doaj.org/article/8cf60e56a0e1457e8f284618cb88b09d
Publikováno v:
Системные гипертензии, Vol 14, Iss 3, Pp 72-78 (2017)
The article considers issues of efficiency and safety of the use of torasemid, a loop diuretic, with the additional property of antagonist of the mineralocorticoid receptor in the treatment of arterial hypertension in different groups of patients.
Externí odkaz:
https://doaj.org/article/9dcc30210694412daa4b13f198ad2ec9
Autor:
N G Poteshkina, A A Troshina
Publikováno v:
Системные гипертензии, Vol 12, Iss 4, Pp 38-41 (2015)
The article reviews the current clinical data on the use of one of the modern pharmacological drugs torasemide (Diuver, Teva Pharmaceutical Industries Ltd., Israel) in the treatment of cardiovascular disease in conditions of comorbidity. Presents a c
Externí odkaz:
https://doaj.org/article/092c95f22526419c8cbd178d85340f41
Publikováno v:
Терапевтический архив, Vol 80, Iss 6, Pp 77-80 (2008)
Externí odkaz:
https://doaj.org/article/24cda5fcad8645228b02d552b62e6d5f
Autor:
Zrno, Julijan
Torasemid je lijek koji pripada skupini diuretika te najveću ulogu ima u liječenju hipertenzije, edema zbog kongestivnog srčanog zatajenja te edema zbog bolesti jetre ili bubrega. Povećana upotreba ovog farmaceutika može uzrokovati akumuliranje
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=57a035e5b1ae::a1e6a6985825bb891a14a5d10bd79acd
https://www.bib.irb.hr/1151697
https://www.bib.irb.hr/1151697
Autor:
Javorić, Kristina
Farmaceutici su kemijski spojevi koji se koriste za liječenje ili sprječavanje bolesti u humanoj i veterinarskoj medicini. S obzirom da su sveprisutni u našem svakodnevnom životu vrlo lako dospijevaju u okoliš. Primarni put njihovog ulaska u oko
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=57a035e5b1ae::05aecdba0a154fb733255fbc8397908d
https://www.bib.irb.hr/1151695
https://www.bib.irb.hr/1151695
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Системные гипертензии, Vol 14, Iss 3, Pp 72-78 (2017)
The article considers issues of efficiency and safety of the use of torasemid, a loop diuretic, with the additional property of antagonist of the mineralocorticoid receptor in the treatment of arterial hypertension in different groups of patients.
Autor:
Mikulčić, Valentina
Dvodimenzionalna tekućinska kromatografija izravno povezanu s masenom spektrometrijom korištena je u analizi razgradnih produkata torasemida nastalih prisilnom razgradnjom. Uzorci torasemida bili su razgrađivani pri različitim uvjetima: 3 sata na
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::c820953951f4536acadcc47c15411a87
https://www.bib.irb.hr/1271985
https://www.bib.irb.hr/1271985
Autor:
Mukhamedova, M. G.
Publikováno v:
Bukovinian Medical Herald; Том 22, № 3 (87) (2018); 42-49
Буковинский медицинский вестник; Том 22, № 3 (87) (2018); 42-49
Буковинський медичний вісник; Том 22, № 3 (87) (2018); 42-49
Буковинский медицинский вестник; Том 22, № 3 (87) (2018); 42-49
Буковинський медичний вісник; Том 22, № 3 (87) (2018); 42-49
Aim: to evaluate the quality of life and functional status of chronic heart failure (CHF) patients due to the standard therapy including loop diuretics such as torasemide or furosemide.Material and methods. The study included 303 patients with CHF of